Literature DB >> 9513654

Viral-induced rhinitis.

B Winther1, J M Gwaltney, N Mygind, J O Hendley.   

Abstract

Upper respiratory viruses cause self-limited illness characterized by acute rhinitis. In rhinovirus colds the symptoms are thought to be caused by the host response rather than viral damage of the nasal epithelium. Rhinovirus triggers an inflammatory cascade, evidenced by the presence of inflammatory mediators (e.g., IL-8) and proinflammatory cytokines (e.g., kinins) in nasal secretions, which results in symptomatic illness. In contrast to rhinovirus and coronavirus, which do not cause discernible epithelial damage, influenza virus and adenovirus do damage the nasal epithelium. Appropriate antiviral therapy will depend on the causative virus. Treatment of rhinovirus colds may require an antiviral agent (e.g., interferon alpha) in combination with antiinflammatory medication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9513654     DOI: 10.2500/105065898782102954

Source DB:  PubMed          Journal:  Am J Rhinol        ISSN: 1050-6586


  22 in total

1.  Accelerated shedding of prions following damage to the olfactory epithelium.

Authors:  Richard A Bessen; Jason M Wilham; Diana Lowe; Christopher P Watschke; Harold Shearin; Scott Martinka; Byron Caughey; James A Wiley
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

Review 2.  Dysfunctional nucleus tractus solitarius: its crucial role in promoting neuropathogenetic cascade of Alzheimer's dementia--a novel hypothesis.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

3.  Seasonal and pandemic human influenza viruses attach better to human upper respiratory tract epithelium than avian influenza viruses.

Authors:  Debby van Riel; Michael A den Bakker; Lonneke M E Leijten; Salin Chutinimitkul; Vincent J Munster; Emmie de Wit; Guus F Rimmelzwaan; Ron A M Fouchier; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Am J Pathol       Date:  2010-02-18       Impact factor: 4.307

4.  Management of respiratory viral infections in hematopoietic cell transplant recipients.

Authors:  Dimpy P Shah; Shashank S Ghantoji; Victor E Mulanovich; Ella J Ariza-Heredia; Roy F Chemaly
Journal:  Am J Blood Res       Date:  2012-11-25

Review 5.  Antimicrobial treatment guidelines for acute bacterial rhinosinusitis.

Authors:  Jack B Anon; Michael R Jacobs; Michael D Poole; Paul G Ambrose; Mark S Benninger; James A Hadley; William A Craig
Journal:  Otolaryngol Head Neck Surg       Date:  2004-01       Impact factor: 3.497

6.  Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers.

Authors:  U Glück; J O Gebbers; R Glück
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Inflammatory patterns of allergic and nonallergic rhinitis.

Authors:  S E Sobol; P Christodoulopoulos; Q A Hamid
Journal:  Curr Allergy Asthma Rep       Date:  2001-05       Impact factor: 4.919

8.  Epstein-barr virus induced cellular changes in nasal mucosa.

Authors:  Matteo Gelardi; Marilena Tomaiuolo; Michele Cassano; Gaspare Besozzi; Maria Luisa Fiorella; Agata Calvario; Maria Antonia Castellano; Pasquale Cassano
Journal:  Virol J       Date:  2006-02-01       Impact factor: 4.099

9.  Human Rhinovirus-induced Proinflammatory Cytokine and Interferon-β Responses in Nasal Epithelial Cells From Chronic Rhinosinusitis Patients.

Authors:  Ji Heui Kim; You Sun Kim; Gye Song Cho; Nam Hee Kim; Chang Hoon Gong; Bong Jae Lee; Yong Ju Jang
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-26       Impact factor: 5.764

10.  Molecular detection of human rhinoviruses in respiratory samples: a comparison of Taqman probe-, SYBR green I- and BOXTO-based real-time PCR assays.

Authors:  Julien Dupouey; Laetitia Ninove; Vanessa Ferrier; Odile Py; Céline Gazin; Laurence Thirion-Perrier; Xavier de Lamballerie
Journal:  Virol J       Date:  2014-02-18       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.